Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
29 pending office actions • 21 art units • 26 examiners • 0 of 29 (0%) have an AI response strategy ready • 21 patents granted in the last 365 days
University of Louisville Research Foundation Inc. has 27 pending office actions in the Biotechnology & Pharmaceuticals technology area. These matters are spread across 24 distinct examiners and 19 distinct art units. This distribution reflects a diverse research output, with the 27 pending office actions touching on many different facets of biotechnology and pharmaceutical science. With 19 distinct art units in play, practitioners must adapt to a range of examiner preferences and art unit policies across the portfolio.
MERRIAM, AARON ROGERS is the busiest examiner, overseeing 2 pending office actions. The fact that 24 distinct examiners are involved for 27 actions indicates that most examiners are handling only a single case for the foundation. Such an array of examiners and units requires a coordinated strategy to ensure consistency in claim construction and legal arguments. The breadth of this activity reflects the foundation's investment in intellectual property, necessitating an approach to managing the various procedural requirements associated with 24 distinct examiners.
Based on the USPTO statutory response window for each pending office action. 12 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 12 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 4 (14%) |
| §103 only | 9 (31%) |
| §102 only | 2 (7%) |
| §112 only | 1 (3%) |
| Double-patenting + other | 1 (3%) |
| Multi-statute (no §101) | 11 (38%) |
| No statute on record | 1 (3%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MERRIAM, AARON ROGERS | 2 | 31.6% | +63.1% |
| KIM, TAEYOON | 2 | 51.5% | +52.1% |
| WANG, RUIXUE | 2 | 57.4% | +17.8% |
| ZHU, JIANJIAN | 1 | 58.8% | +82.4% |
| KHANDKER, RAIHAN R | 1 | 64.2% | +57.2% |
| DIBRINO, MARIANNE | 1 | 42.8% | +42.2% |
| SHERMAN, ERIC SCOTT | 1 | 73.5% | +18.5% |
| MACHNESS, ARIELLA | 1 | 61.9% | +28.5% |
| MULLINS, JESSICA LYNN | 1 | 49.5% | +34.0% |
| SCHUBERG, LAURA J | 1 | 23.6% | +37.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17544279 | ELECTROCHEMICAL ENERGY STORAGE DEVICES COMPRISING HALIDE-CONTAINING LITHIUM ARGYRODITE SOLID ELECTROLYTES | ORTIZ, ARYANA YASMINE | 117d overdue |
| 17780961 | BIOMASS-BASED SOLID COMPOSITE ELECTROLYTES FOR BATTERIES | NGUYEN, KEVIN NMN | 56d overdue |
| 17641787 | ANTI-NUCLEOLIN AGENT-PEG-CONJUGATED NANOPARTICLES | MEJIAS, SAMANTHA LEE | 3d overdue |
| 18020235 | METHODS AND COMPOSITIONS FOR TREATING PERIODONTAL DISEASE | WEBB, WALTER E | 6d |
| 17862892 | 3-D BIOPRINTING COMPRISING BIOLOGICALLY-RELEVANT MATERIALS AND RELATED METHODS | KIM, TAEYOON | 12d |
| 18274412 | INHIBITION OF DEGRANULATION OF NEUTROPHIL CELLS IN COVID-19 PATIENTS | BANERJEE, KOYELI | 13d |
| 18008391 | IDENTIFICATION OF LOW-DENSITY INFLAMMATORY NEUTROPHILS IN SEVERE COVID-19 PATIENTS | WANG, RUIXUE | 20d |
| 18230278 | METHOD OF TREATMENT FOR HEART FAILURE USING STEM CELLS | SCHUBERG, LAURA J | 34d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17862892 | 3-D BIOPRINTING COMPRISING BIOLOGICALLY-RELEVANT MATERIALS AND RELATED METHODS | KIM, TAEYOON | 12d |
| 18008391 | IDENTIFICATION OF LOW-DENSITY INFLAMMATORY NEUTROPHILS IN SEVERE COVID-19 PATIENTS | WANG, RUIXUE | 20d |
| 18233416 | IN-PROCESS ULTRASONIC POLLING OF 3D PRINTED CRYSTALLINE/SEMICRYSTALLINE ELECTROACTIVE POLYMERS | MACHNESS, ARIELLA | 29d |
| 18124656 | HUMAN FACILITATING CELLS | KIM, TAEYOON | 29d |
| 18230278 | METHOD OF TREATMENT FOR HEART FAILURE USING STEM CELLS | SCHUBERG, LAURA J | 34d |
| 18981938 | PHYSIOLOGICAL BIOMIMETIC CULTURE SYSTEM FOR HEART SLICES | ZHU, JIANJIAN | — |
| 18551043 | LEFT ATRIAL APPENDAGE CLOSURE DEVICE WITH CATHETER-BASED DELIVERY | KHANDKER, RAIHAN R | — |
| 18277684 | Actinohivin Variant Polypeptides and Related Methods | DIBRINO, MARIANNE | — |
| Art Unit | Apps |
|---|---|
| 1631 | 3 |
| 1641 | 2 |
| 3791 | 2 |
| 1672 | 2 |
| 1618 | 2 |
| 3771 | 1 |
| 1736 | 1 |
| 1743 | 1 |
| 3796 | 1 |
| 1658 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18981938 | PHYSIOLOGICAL BIOMIMETIC CULTURE SYSTEM FOR HEART SLICES | ZHU, JIANJIAN | — | §103 | Non-Final OA | — | Pending | Dec 16, 2024 |
| 18551043 | LEFT ATRIAL APPENDAGE CLOSURE DEVICE WITH CATHETER-BASED DELIVERY | KHANDKER, RAIHAN R | 3771 | §103 | Final Rejection | — | Pending | Sep 18, 2023 |
| 18277684 | Actinohivin Variant Polypeptides and Related Methods | DIBRINO, MARIANNE | 1641 | §103§112DP | Final Rejection | — | Pending | Aug 17, 2023 |
| 18450060 | ULTRATHIN NANORIBBONS OF HIGHLY ANISOTROPIC LAYERED MATERIAL AND METHOD OF PRODUCTION | SHERMAN, ERIC SCOTT | 1736 | §102 | Non-Final OA | — | Pending | Aug 15, 2023 |
| 18233416 | IN-PROCESS ULTRASONIC POLLING OF 3D PRINTED CRYSTALLINE/SEMICRYSTALLINE ELECTROACTIVE POLYMERS | MACHNESS, ARIELLA | 1743 | §103 | Final Rejection | 29d | Pending | Aug 14, 2023 |
| 18447661 | SYSTEMS AND METHODS FOR IMPROVING MULTIPLE PHYSIOLOGICAL FUNCTIONS USING NEUROSTIMULATION | MULLINS, JESSICA LYNN | 3796 | §102 | Non-Final OA | — | Pending | Aug 10, 2023 |
| 18230278 | METHOD OF TREATMENT FOR HEART FAILURE USING STEM CELLS | SCHUBERG, LAURA J | 1631 | §103 | Final Rejection | 34d | Pending | Aug 04, 2023 |
| 18274412 | INHIBITION OF DEGRANULATION OF NEUTROPHIL CELLS IN COVID-19 PATIENTS | BANERJEE, KOYELI | 1658 | §103§112 | Final Rejection | 13d | Pending | Jul 26, 2023 |
| 18261950 | ACTINOHIVIN VARIANT POLYPEPTIDES AND RELATED METHODS | ALFANO, ALAN | 1641 | §101§102§103§112DP | Non-Final OA | — | Pending | Jul 18, 2023 |
| 18333400 | METHOD OF INHIBITING LUNG OR BREAST CANCER GROWTH WITH ENGINEERED EMBRYONIC STEM-CELL DERIVED EXOSOMES COMPOSITIONS | STOICA, ELLY GERALD | 1647 | §103 | Non-Final OA | — | Pending | Jun 12, 2023 |
| 18253780 | METHODS FOR OPTIMIZATION OF PLACEMENT OF SPINAL CORD EPIDURAL STIMULATION UNIT | THOMAS, SOUMYA | — | §101§103 | Non-Final OA | — | Pending | May 20, 2023 |
| 18307512 | SYSTEMS AND METHODS TO MEASURE AND IMPROVE EYE MOVEMENTS AND FIXATION | MERRIAM, AARON ROGERS | 3791 | §103§112 | Final Rejection | — | Pending | Apr 26, 2023 |
| 18248491 | PROBIOTIC DELIVERY SYSTEMS AND METHODS OF MAKING AND USING | HINES, JANA A | 1645 | §103 | Non-Final OA | 29d | Pending | Apr 10, 2023 |
| 18030174 | GRIFFITHSIN FOR RHABDOVIRIDAE INFECTIONS | DABKOWSKI, ERINNE R | 1654 | §103 | Final Rejection | 14d | Pending | Apr 04, 2023 |
| 18124656 | HUMAN FACILITATING CELLS | KIM, TAEYOON | 1631 | Other | Final Rejection | 29d | Pending | Mar 22, 2023 |
| 18020235 | METHODS AND COMPOSITIONS FOR TREATING PERIODONTAL DISEASE | WEBB, WALTER E | 1612 | §102§103§112 | Non-Final OA | 6d | Pending | Feb 07, 2023 |
| 18162777 | CELL LINES, SYSTEMS, KITS, AND METHODS FOR DETERMINING THE SPECIFICITY AND/OR POTENCY OF CERAMIDASE INHIBITORS | TICHY, JENNIFER M.H. | 1637 | §103§112 | Non-Final OA | — | Pending | Feb 01, 2023 |
| 18013010 | FIBER PRETREATMENT FOR IMPROVED NATURAL FIBER - POLYMER COMPOSITE FEEDSTOCK PRODUCTION | EASHOO, MARK | 1767 | §103§112 | Non-Final OA | — | Pending | Dec 27, 2022 |
| 18008391 | IDENTIFICATION OF LOW-DENSITY INFLAMMATORY NEUTROPHILS IN SEVERE COVID-19 PATIENTS | WANG, RUIXUE | 1672 | §101§102§112 | Non-Final OA | 20d | Pending | Dec 05, 2022 |
| 17997764 | BIOMIMETIC HEART TISSUE CULTURE SYSTEM | HENKEL, DANIELLE B | 1799 | §103§112 | Non-Final OA | — | Pending | Nov 02, 2022 |
| 17913575 | METHODS AND COMPOSITIONS FOR DETECTING VIRUSES | WANG, RUIXUE | 1672 | §103 | Final Rejection | — | Pending | Sep 22, 2022 |
| 17862892 | 3-D BIOPRINTING COMPRISING BIOLOGICALLY-RELEVANT MATERIALS AND RELATED METHODS | KIM, TAEYOON | 1631 | §103§112Other | Final Rejection | 12d | Pending | Jul 12, 2022 |
| 17780961 | BIOMASS-BASED SOLID COMPOSITE ELECTROLYTES FOR BATTERIES | NGUYEN, KEVIN NMN | 1752 | §103§112 | Non-Final OA | 56d overdue | Pending | May 27, 2022 |
| 17741686 | ANTI-NUCLEOLIN AGENT-CONJUGATED NANOPARTICLES | JONES, DAMERON LEVEST | 1618 | §102§112Other | Final Rejection | — | Pending | May 11, 2022 |
| 17641787 | ANTI-NUCLEOLIN AGENT-PEG-CONJUGATED NANOPARTICLES | MEJIAS, SAMANTHA LEE | 1618 | §102§103§112Other | Final Rejection | 3d overdue | Pending | Mar 09, 2022 |
| 17639825 | SYSTEMS AND METHODS FOR DETECTION AND GRADING OF DIABETIC RETINOPATHY | MERRIAM, AARON ROGERS | 3791 | §101§103 | Final Rejection | — | Pending | Mar 02, 2022 |
| 17629309 | IMMUNOMODULATORY COMPOSITIONS AND METHODS OF USING | HILL, MYRON G | 1671 | §112 | Final Rejection | — | Pending | Jan 21, 2022 |
| 17544279 | ELECTROCHEMICAL ENERGY STORAGE DEVICES COMPRISING HALIDE-CONTAINING LITHIUM ARGYRODITE SOLID ELECTROLYTES | ORTIZ, ARYANA YASMINE | 1751 | §103§112 | Final Rejection | 117d overdue | Pending | Dec 07, 2021 |
| 16789572 | MODULAR HARNESS FOR PATIENTS WITH POST-NEUROLOGIC INJURY | MILLER, CHRISTOPHER E | 3785 | §103 | Non-Final OA | — | Pending | Feb 13, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial